chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Peripheral swelling, Pruritus, Skin warm, Vaccination site rash
Clinical narrative: whole arm is swollen; warm to touch; incredibly itchy; can see the redness; Rash at the site of the injection; A spontaneous report was received from a consumer report] concerning a female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and developed a rash at the site of injection/injection site rash, swollen arm/peripheral swelling, warm to touch/skin warm, incredibly itchy/pruritus, and redness/erythema  The patient's medical history was not provided.  No relevant concomitant medications were reported.   On 18 Jan 2021 the patient received their first of two planned doses of mRNA-1273 (lot number 027L20A) intramuscularly for prophylaxis of COVID-19 infection.   The patient developed a rash at the injection site, her arm was swollen, warm to the touch, itchy, and red on an unknown date.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not provided.   The outcome of the events rash at the injection site, arm was swollen, warm to the touch, itchy, and red were not reported.  Reporter causality for the events was not provided.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Limb discomfort, Pain in extremity
Clinical narrative: pain in arm; arm felt heavy; could not sleep; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (could not sleep) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced INSOMNIA (could not sleep). At the time of the report, INSOMNIA (could not sleep) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products included diabetes medication unspecified. No treatment information was provided.   This case was linked to MOD-2021-080632, MOD-2021-015804 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 18-Apr-2021: Information on dose 2 was provided. On 19-Apr-2021: Reporter's contact information was updated.
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during breast feeding
Clinical narrative: Breastfeeding; A spontaneous report was received from a consumer concerning a female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and was breastfeeding/maternal exposure during breast feeding .  The patient's medical history was not provided.  No relevant concomitant medications were reported.   On 22 Dec 2020, the same day as the onset of the event, the patient received their first of two planned doses of mRNA-1273 (batch number not provided) intramuscularly for prophylaxis of COVID-19 infection.   The patient was breastfeeding at the time she received her first dose of mRNA-1273.  No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not provided.   The outcome of the event breastfeeding was recovered.  Reporter causality for the event was not provided.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hyperhidrosis, Peripheral swelling, Vaccination site cellulitis, Vaccination site erythema
Clinical narrative: Headache; Sweating; Hand swelling; Injection site induration; Vaccination site cellulitis; vaccination site pruritus; injection site  erythema; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE CELLULITIS (Vaccination site cellulitis), HEADACHE (Headache), HYPERHIDROSIS (Sweating), PERIPHERAL SWELLING (Hand swelling) and VACCINATION SITE PRURITUS (vaccination site pruritus) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cellulitis.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE CELLULITIS (Vaccination site cellulitis), VACCINATION SITE PRURITUS (vaccination site pruritus) and INJECTION SITE ERYTHEMA ( injection site  erythema). On 23-Jan-2021, the patient experienced HEADACHE (Headache), HYPERHIDROSIS (Sweating), PERIPHERAL SWELLING (Hand swelling) and INJECTION SITE INDURATION (Injection site induration). On 23-Jan-2021, VACCINATION SITE PRURITUS (vaccination site pruritus) and INJECTION SITE ERYTHEMA ( injection site  erythema) had resolved. At the time of the report, VACCINATION SITE CELLULITIS (Vaccination site cellulitis), HEADACHE (Headache), HYPERHIDROSIS (Sweating), PERIPHERAL SWELLING (Hand swelling) and INJECTION SITE INDURATION (Injection site induration) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The injection site is clover shaped, hot and touch to hard.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site induration, Vaccination site pruritus
Clinical narrative: Headache; Sweating; Hand swelling; Injection site induration; Vaccination site cellulitis; vaccination site pruritus; injection site  erythema; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE CELLULITIS (Vaccination site cellulitis), HEADACHE (Headache), HYPERHIDROSIS (Sweating), PERIPHERAL SWELLING (Hand swelling) and VACCINATION SITE PRURITUS (vaccination site pruritus) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cellulitis.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE CELLULITIS (Vaccination site cellulitis), VACCINATION SITE PRURITUS (vaccination site pruritus) and INJECTION SITE ERYTHEMA ( injection site  erythema). On 23-Jan-2021, the patient experienced HEADACHE (Headache), HYPERHIDROSIS (Sweating), PERIPHERAL SWELLING (Hand swelling) and INJECTION SITE INDURATION (Injection site induration). On 23-Jan-2021, VACCINATION SITE PRURITUS (vaccination site pruritus) and INJECTION SITE ERYTHEMA ( injection site  erythema) had resolved. At the time of the report, VACCINATION SITE CELLULITIS (Vaccination site cellulitis), HEADACHE (Headache), HYPERHIDROSIS (Sweating), PERIPHERAL SWELLING (Hand swelling) and INJECTION SITE INDURATION (Injection site induration) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The injection site is clover shaped, hot and touch to hard.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain, Pyrexia
Clinical narrative: On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (Body ache), FATIGUE (Fatigue) and PYREXIA (Low grade fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) at an unspecified dose and frequency. At the time of the report, PAIN (Body ache), FATIGUE (Fatigue) and PYREXIA (Low grade fever) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Based on the current available information and temporal association between the use of mRNA-1273 and the onset of the events, a causal relationship cannot be excluded. fatigue and fever are consistent with the product safety profile.; Sender's Comments: Based on the current available information and temporal association between the use of mRNA-1273 and the onset of the events, a causal relationship cannot be excluded. fatigue and fever are consistent with the product safety profile.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Corneal irritation, Dry eye, Rash pruritic, Urticaria
Clinical narrative: eyes became so dry; irritation on both corneas; welts on my right lower jaw; s first appeared as a rash, then a couple of big lumps that were very itchy; This spontaneous case was reported by a consumer and describes the occurrence of DRY EYE (eyes became so dry), CORNEAL IRRITATION (irritation on both corneas), URTICARIA (welts on my right lower jaw) and RASH PRURITIC (s first appeared as a rash, then a couple of big lumps that were very itchy) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     The patient's past medical history included Thyroid infection in 1985, Hypertension in 1990, Gout in 2019, Bone density abnormal, Pelvic pain in 2020 and Anxiety in 2019. Concomitant products included ASCORBIC ACID, BETACAROTENE, CUPRIC OXIDE, TOCOPHERYL ACETATE, ZINC OXIDE (PRESERVISION), VITAMIN B [VITAMIN B NOS], VITAMIN C [ASCORBIC ACID], VITAMIN D3, CALCIUM, MAGNESIUM and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced DRY EYE (eyes became so dry), CORNEAL IRRITATION (irritation on both corneas), URTICARIA (welts on my right lower jaw) and RASH PRURITIC (s first appeared as a rash, then a couple of big lumps that were very itchy). The patient was treated with DOXYCYCLINE ongoing since an unknown date for Rash, at a dose of 100 mg twice a day and METRONIDAZOLE ongoing since an unknown date for Rash, at an unspecified dose and frequency. At the time of the report, DRY EYE (eyes became so dry), CORNEAL IRRITATION (irritation on both corneas), URTICARIA (welts on my right lower jaw) and RASH PRURITIC (s first appeared as a rash, then a couple of big lumps that were very itchy) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: positive (Positive) did get tested and did get COVID.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.       Con. med: Turmeric/ginger Treatment: ointment and artificial tears   Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: Follow up received on 21-Apr-2021 patient medical history and concomitant medications included.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Arthralgia, Back pain, Body temperature, Chills
Clinical narrative: Bit of tough breathing; Stomach problems; pain in the abdomen; slight aches and pain; Discomfort; Aches in his back; Chills; temperature which was only 1 degree above his normal; Aches in his shoulder; Aches in the extremities; achy; body aches; Sweats; Almost like the flu; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweats), INFLUENZA LIKE ILLNESS (Almost like the flu), DYSPNOEA (Bit of tough breathing), ABDOMINAL PAIN UPPER (Stomach problems; pain in the abdomen) and PAIN (slight aches and pain) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Knee pain (start/stop date, ongoing details not provided).    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced HYPERHIDROSIS (Sweats), INFLUENZA LIKE ILLNESS (Almost like the flu), ABDOMINAL PAIN UPPER (Stomach problems; pain in the abdomen), PAIN (slight aches and pain), DISCOMFORT (Discomfort), BACK PAIN (Aches in his back), CHILLS (Chills), PYREXIA (temperature which was only 1 degree above his normal), ARTHRALGIA (Aches in his shoulder) and MYALGIA (Aches in the extremities; achy; body aches). On an unknown date, the patient experienced DYSPNOEA (Bit of tough breathing). At the time of the report, HYPERHIDROSIS (Sweats), PAIN (slight aches and pain), CHILLS (Chills), ARTHRALGIA (Aches in his shoulder) and MYALGIA (Aches in the extremities; achy; body aches) was resolving, INFLUENZA LIKE ILLNESS (Almost like the flu), ABDOMINAL PAIN UPPER (Stomach problems; pain in the abdomen), DISCOMFORT (Discomfort) and BACK PAIN (Aches in his back) had not resolved and DYSPNOEA (Bit of tough breathing) and PYREXIA (temperature which was only 1 degree above his normal) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2021, Body temperature: 1 degree higher than normal (High) high.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Relevant concomitant medication included pain medication for knee pain (not specified).   Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 18-Feb-2021: Follow-up information included additional adverse events. On 16-Apr-2021: Follow-up information contains no new information.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Discomfort, Dyspnoea, Hyperhidrosis, Influenza like illness, Myalgia
Clinical narrative: Bit of tough breathing; Stomach problems; pain in the abdomen; slight aches and pain; Discomfort; Aches in his back; Chills; temperature which was only 1 degree above his normal; Aches in his shoulder; Aches in the extremities; achy; body aches; Sweats; Almost like the flu; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweats), INFLUENZA LIKE ILLNESS (Almost like the flu), DYSPNOEA (Bit of tough breathing), ABDOMINAL PAIN UPPER (Stomach problems; pain in the abdomen) and PAIN (slight aches and pain) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Knee pain (start/stop date, ongoing details not provided).    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced HYPERHIDROSIS (Sweats), INFLUENZA LIKE ILLNESS (Almost like the flu), ABDOMINAL PAIN UPPER (Stomach problems; pain in the abdomen), PAIN (slight aches and pain), DISCOMFORT (Discomfort), BACK PAIN (Aches in his back), CHILLS (Chills), PYREXIA (temperature which was only 1 degree above his normal), ARTHRALGIA (Aches in his shoulder) and MYALGIA (Aches in the extremities; achy; body aches). On an unknown date, the patient experienced DYSPNOEA (Bit of tough breathing). At the time of the report, HYPERHIDROSIS (Sweats), PAIN (slight aches and pain), CHILLS (Chills), ARTHRALGIA (Aches in his shoulder) and MYALGIA (Aches in the extremities; achy; body aches) was resolving, INFLUENZA LIKE ILLNESS (Almost like the flu), ABDOMINAL PAIN UPPER (Stomach problems; pain in the abdomen), DISCOMFORT (Discomfort) and BACK PAIN (Aches in his back) had not resolved and DYSPNOEA (Bit of tough breathing) and PYREXIA (temperature which was only 1 degree above his normal) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2021, Body temperature: 1 degree higher than normal (High) high.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Relevant concomitant medication included pain medication for knee pain (not specified).   Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 18-Feb-2021: Follow-up information included additional adverse events. On 16-Apr-2021: Follow-up information contains no new information.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Bit of tough breathing; Stomach problems; pain in the abdomen; slight aches and pain; Discomfort; Aches in his back; Chills; temperature which was only 1 degree above his normal; Aches in his shoulder; Aches in the extremities; achy; body aches; Sweats; Almost like the flu; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweats), INFLUENZA LIKE ILLNESS (Almost like the flu), DYSPNOEA (Bit of tough breathing), ABDOMINAL PAIN UPPER (Stomach problems; pain in the abdomen) and PAIN (slight aches and pain) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Knee pain (start/stop date, ongoing details not provided).    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced HYPERHIDROSIS (Sweats), INFLUENZA LIKE ILLNESS (Almost like the flu), ABDOMINAL PAIN UPPER (Stomach problems; pain in the abdomen), PAIN (slight aches and pain), DISCOMFORT (Discomfort), BACK PAIN (Aches in his back), CHILLS (Chills), PYREXIA (temperature which was only 1 degree above his normal), ARTHRALGIA (Aches in his shoulder) and MYALGIA (Aches in the extremities; achy; body aches). On an unknown date, the patient experienced DYSPNOEA (Bit of tough breathing). At the time of the report, HYPERHIDROSIS (Sweats), PAIN (slight aches and pain), CHILLS (Chills), ARTHRALGIA (Aches in his shoulder) and MYALGIA (Aches in the extremities; achy; body aches) was resolving, INFLUENZA LIKE ILLNESS (Almost like the flu), ABDOMINAL PAIN UPPER (Stomach problems; pain in the abdomen), DISCOMFORT (Discomfort) and BACK PAIN (Aches in his back) had not resolved and DYSPNOEA (Bit of tough breathing) and PYREXIA (temperature which was only 1 degree above his normal) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2021, Body temperature: 1 degree higher than normal (High) high.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Relevant concomitant medication included pain medication for knee pain (not specified).   Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 18-Feb-2021: Follow-up information included additional adverse events. On 16-Apr-2021: Follow-up information contains no new information.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Her left arm was itching and hurting; arm was hurting; was red; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Her left arm was itching and hurting), VACCINATION SITE PAIN (arm was hurting), VACCINATION SITE ERYTHEMA (was red), CHILLS (chills) and PYREXIA (fever) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Thyroid disorder, Fluid retention and Sinus pain. Concomitant products included TORSEMIDE for Fluid retention, POTASSIUM, ASCORBIC ACID, ERGOCALCIFEROL, NICOTINAMIDE, RETINOL, RIBOFLAVIN, THIAMINE HYDROCHLORIDE (VITAMINS [ASCORBIC ACID;ERGOCALCIFEROL;NICOTINAMIDE;RETINOL;RIBOFLAVIN;THIAMINE HYDROCHLORIDE]) and DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN (MUCINEX DM) for an unknown indication.    On 22-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 23-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Her left arm was itching and hurting), VACCINATION SITE PAIN (arm was hurting), VACCINATION SITE ERYTHEMA (was red), CHILLS (chills) and PYREXIA (fever). On 25-Jan-2021, VACCINATION SITE PRURITUS (Her left arm was itching and hurting), VACCINATION SITE PAIN (arm was hurting), VACCINATION SITE ERYTHEMA (was red), CHILLS (chills) and PYREXIA (fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included Zyrtec; Sender's Comments: Based on the current available information and temporal association between the use of mRNA-1273 and the onset of the events, a causal relationship cannot be excluded. The reported events are consistent with the product safety profile
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Nausea, Pyrexia
Clinical narrative: Chills; fever; Exhaustion; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), PYREXIA (fever), FATIGUE (Exhaustion) and NAUSEA (Nausea) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced CHILLS (Chills), PYREXIA (fever), FATIGUE (Exhaustion) and NAUSEA (Nausea). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, CHILLS (Chills), PYREXIA (fever), FATIGUE (Exhaustion) and NAUSEA (Nausea) outcome was unknown.            No concomitant medications were reported. Action taken with mRNA-1273 in response to the event was not applicable. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia, Rhinorrhoea
Clinical narrative: Runny nose; Running low grade fever 99.2; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Runny nose) and PYREXIA (Running low grade fever 99.2) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RHINORRHOEA (Runny nose) and PYREXIA (Running low grade fever 99.2). At the time of the report, RHINORRHOEA (Runny nose) and PYREXIA (Running low grade fever 99.2) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99.2 (Low) 99.2.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient thought runny nose may be due to allergy.  Concomitant product use was not provided by the reporter.  No treatment information was provided.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pyrexia
Clinical narrative: Body aches; Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body aches), PYREXIA (Fever) and HEADACHE (Headache) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 026L20A) for COVID-19 vaccination.     Concurrent medical conditions included Cholesterol and Blood pressure.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced MYALGIA (Body aches), PYREXIA (Fever) and HEADACHE (Headache). At the time of the report, MYALGIA (Body aches), PYREXIA (Fever) and HEADACHE (Headache) outcome was unknown. Not Provided
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Pain, Pyrexia
Clinical narrative: ache; fever(101.2 F); felt without energy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (ache), PYREXIA (fever(101.2 F)) and FATIGUE (felt without energy) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 011L20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood cholesterol abnormal.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced PAIN (ache), PYREXIA (fever(101.2 F)) and FATIGUE (felt without energy). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] on 03-Feb-2021 for Fever, at a dose of UNK dosage form. At the time of the report, PAIN (ache), PYREXIA (fever(101.2 F)) and FATIGUE (felt without energy) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Feb-2021, Body temperature: 101.2 f (Inconclusive) 101.2 Fahrenheit.         Concomitant products included blood thinner medicine and cholesterol medicine.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling hot, Pruritus, Rash
Clinical narrative: Itchiness in the face; Rash in the left side of face; Rash is little bit warm; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchiness in the face), FEELING HOT (Rash is little bit warm) and RASH (Rash in the left side of face) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concomitant products included LISINOPRIL, SIMVASTATIN, FINASTERIDE and TAMSULOSIN for an unknown indication.    On 02-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced PRURITUS (Itchiness in the face) and RASH (Rash in the left side of face). In February 2021, the patient experienced FEELING HOT (Rash is little bit warm). At the time of the report, PRURITUS (Itchiness in the face), FEELING HOT (Rash is little bit warm) and RASH (Rash in the left side of face) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site haemorrhage
Clinical narrative: (METFORMIN ER) and ATORVASTATIN for an unknown indication.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced VACCINATION SITE HAEMORRHAGE (Little bleeding at the injection site during vaccination and a bandage was out on it). At the time of the report, VACCINATION SITE HAEMORRHAGE (Little bleeding at the injection site during vaccination and a bandage was out on it) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a casual relationship cannot be excluded.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Muscle spasms, Nausea
Clinical narrative: Stomach Pain/cramps; stomach pains/cramps; felt as if she wanted to throw up; This spontaneous case was reported by a patient and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach Pain/cramps), MUSCLE SPASMS (stomach pains/cramps) and NAUSEA (felt as if she wanted to throw up) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach Pain/cramps), MUSCLE SPASMS (stomach pains/cramps) and NAUSEA (felt as if she wanted to throw up). At the time of the report, ABDOMINAL PAIN UPPER (Stomach Pain/cramps), MUSCLE SPASMS (stomach pains/cramps) and NAUSEA (felt as if she wanted to throw up) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were not reported. No treatment medications were not provided.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: The site is not itchy now but when it was in the past; Noticed a red area that looks like bug bite at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Noticed a red area that looks like bug bite at the site of injection) and VACCINATION SITE PRURITUS (The site is not itchy now but when it was in the past) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L29A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Noticed a red area that looks like bug bite at the site of injection). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (The site is not itchy now but when it was in the past). At the time of the report, VACCINATION SITE ERYTHEMA (Noticed a red area that looks like bug bite at the site of injection) had not resolved and VACCINATION SITE PRURITUS (The site is not itchy now but when it was in the past) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Dysphonia, Nasal congestion
Clinical narrative: Hoarseness; Congestion; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of DYSPHONIA (Hoarseness) and NASAL CONGESTION (Congestion) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Atrial fibrillation (Medical history reported as A-fib). Concurrent medical conditions included Diabetes (Medical history reported as diabetes).    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced DYSPHONIA (Hoarseness) and NASAL CONGESTION (Congestion). At the time of the report, DYSPHONIA (Hoarseness) and NASAL CONGESTION (Congestion) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided.   Reporter did not allow further contact
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, SARS-CoV-2 test, Vomiting
Clinical narrative: Neurologist said it was Hemiballismus and also could have been a chorea episode; disorientation; was sitting on a chair and started having involuntary movements with his arms and legs, that lasted; he did not recall what was going on; Neurologist said it was Hemiballismus and also could have been a chorea episode; threw up while he was in bed; nausea; This spontaneous case was reported by a patient and describes the occurrence of BALLISMUS (Neurologist said it was Hemiballismus and also could have been a chorea episode), DISORIENTATION (disorientation), DYSKINESIA (was sitting on a chair and started having involuntary movements with his arms and legs, that lasted), MEMORY IMPAIRMENT (he did not recall what was going on) and CHOREA (Neurologist said it was Hemiballismus and also could have been a chorea episode) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Dementia on 06-Mar-2018, Hemiballismus and COVID-19. Concurrent medical conditions included Hypertension since January 1980. Concomitant products included SULFAMETHOXAZOLE, TRIMETHOPRIM (SMZ-TMP DS) for Infection, SULFAMETHOXAZOLE, TRIMETHOPRIM (BACTRIM), TAMSULOSIN HYDROCHLORIDE (FLOMAX RELIEF), ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), CARBIDOPA, LEVODOPA (SINEMET), CITALOPRAM, VALPROATE SEMISODIUM (DEPAKOTE), MELATONIN, VALPROATE SEMISODIUM (DIVALPROEX), QUETIAPINE, FINASTERIDE and TAMSULOSIN for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced BALLISMUS (Neurologist said it was Hemiballismus and also could have been a chorea episode), DISORIENTATION (disorientation), DYSKINESIA (was sitting on a chair and started having involuntary movements with his arms and legs, that lasted), MEMORY IMPAIRMENT (he did not recall what was going on), CHOREA (Neurologist said it was Hemiballismus and also could have been a chorea episode), VOMITING (threw up while he was in bed) and NAUSEA (nausea). On 24-Jan-2021, BALLISMUS (Neurologist said it was Hemiballismus and also could have been a chorea episode), DISORIENTATION (disorientation), DYSKINESIA (was sitting on a chair and started having involuntary movements with his arms and legs, that lasted), MEMORY IMPAIRMENT (he did not recall what was going on), CHOREA (Neurologist said it was Hemiballismus and also could have been a chorea episode), VOMITING (threw up while he was in bed) and NAUSEA (nausea) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.     mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was withdrawn on an unknown date.       Treatment was not specified   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: VAERF is  ,Contact details, Events updated
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Parkinson's disease.    On 03-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced PAIN (Pain). At the time of the report, PAIN (Pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Fatigue, Full blood count, Influenza like illness, Lymphadenopathy
Clinical narrative: Chronic fatigue, on and off flu like symptoms, swollen glands body muscle nerve pain migraine 75 % worse
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Myalgia, Neuralgia, Pain
Clinical narrative: Chronic fatigue, on and off flu like symptoms, swollen glands body muscle nerve pain migraine 75 % worse
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Eye pain, Headache, Intraocular pressure increased, Iridocyclitis
Clinical narrative: I received my first Pfizer COVID19 vaccination 12/18/20 at my hospital (I work as a physician). Sometime between 12/24/20-1/7/21 I developed some L eye pain with reading. It felt like a deep ache in my eye. This went away after a few minutes after I took a break from reading and this is the first time I've ever had this sort of sensation. I received my second Pfizer COVID 19 vaccine on 1/8/21 as scheduled. The eye pain continued to occur intermittently (maybe once every 1-2 weeks over the course of Jan/Feb 2021) and I thought perhaps I needed new glasses. In March 2021 the pain became more frequent (occurring at least once a week or more) and I began to think my L eye vision was becoming a little blurry. In March, I also noted occasional generalized headaches much more frequently than usual (I am prone to stress related headaches maybe once a month at most). I also noticed my L eye was becoming red. Due to my history of an ocular autoimmune disease affecting the conjunctiva (ocular cicatricial pemphigoid) which had been in remission for years, and the fact that I was also working full time as a physician in a fellowship program, I initially thought these symptoms could be related to work-related stress and lack of sleep or relapse of my ocular cicatricial pemphigoid.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Iritis, Ocular hyperaemia, Optic nerve disorder, Uveitic glaucoma, Vision blurred
Clinical narrative: I received my first Pfizer COVID19 vaccination 12/18/20 at my hospital (I work as a physician). Sometime between 12/24/20-1/7/21 I developed some L eye pain with reading. It felt like a deep ache in my eye. This went away after a few minutes after I took a break from reading and this is the first time I've ever had this sort of sensation. I received my second Pfizer COVID 19 vaccine on 1/8/21 as scheduled. The eye pain continued to occur intermittently (maybe once every 1-2 weeks over the course of Jan/Feb 2021) and I thought perhaps I needed new glasses. In March 2021 the pain became more frequent (occurring at least once a week or more) and I began to think my L eye vision was becoming a little blurry. In March, I also noted occasional generalized headaches much more frequently than usual (I am prone to stress related headaches maybe once a month at most). I also noticed my L eye was becoming red. Due to my history of an ocular autoimmune disease affecting the conjunctiva (ocular cicatricial pemphigoid) which had been in remission for years, and the fact that I was also working full time as a physician in a fellowship program, I initially thought these symptoms could be related to work-related stress and lack of sleep or relapse of my ocular cicatricial pemphigoid.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Visual acuity reduced, Visual field defect, Visual impairment
Clinical narrative: I received my first Pfizer COVID19 vaccination 12/18/20 at my hospital (I work as a physician). Sometime between 12/24/20-1/7/21 I developed some L eye pain with reading. It felt like a deep ache in my eye. This went away after a few minutes after I took a break from reading and this is the first time I've ever had this sort of sensation. I received my second Pfizer COVID 19 vaccine on 1/8/21 as scheduled. The eye pain continued to occur intermittently (maybe once every 1-2 weeks over the course of Jan/Feb 2021) and I thought perhaps I needed new glasses. In March 2021 the pain became more frequent (occurring at least once a week or more) and I began to think my L eye vision was becoming a little blurry. In March, I also noted occasional generalized headaches much more frequently than usual (I am prone to stress related headaches maybe once a month at most). I also noticed my L eye was becoming red. Due to my history of an ocular autoimmune disease affecting the conjunctiva (ocular cicatricial pemphigoid) which had been in remission for years, and the fact that I was also working full time as a physician in a fellowship program, I initially thought these symptoms could be related to work-related stress and lack of sleep or relapse of my ocular cicatricial pemphigoid.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Acoustic stimulation tests abnormal, Deafness unilateral, Headache, Immediate post-injection reaction, Mobility decreased
Clinical narrative: I had side effects immediately after my first Pfizer dose on July 2, 2021  My head started pounding right after I got the vaccine. After 5 min my neck hurts so bad that I couldn?t move it. But the worst side effects happened After 3 days from my first vaccine shot I started with Vertigo/Ringing in the ear/Tinnitus.  And leaving me  deaf from my left ear now.  My ear examination on August 2, 2021 showed that I?m 100% deaf from my left ear. I can?t no hear nothing on that side now. As now, August 11, 2021 I have been on medicine for vertigo, and steroids to see if I can get my ear function again. I have been spending money on doctors and exam out of packet because I don?t have any kind of health insurance. So as you can se now. I really need help with this. Please reach out to me if you can help.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Tinnitus, Vertigo
Clinical narrative: I had side effects immediately after my first Pfizer dose on July 2, 2021  My head started pounding right after I got the vaccine. After 5 min my neck hurts so bad that I couldn?t move it. But the worst side effects happened After 3 days from my first vaccine shot I started with Vertigo/Ringing in the ear/Tinnitus.  And leaving me  deaf from my left ear now.  My ear examination on August 2, 2021 showed that I?m 100% deaf from my left ear. I can?t no hear nothing on that side now. As now, August 11, 2021 I have been on medicine for vertigo, and steroids to see if I can get my ear function again. I have been spending money on doctors and exam out of packet because I don?t have any kind of health insurance. So as you can se now. I really need help with this. Please reach out to me if you can help.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Malaise
Clinical narrative: Didn't feel good; headache; fatigue; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of MALAISE (Didn't feel good), HEADACHE (headache) and FATIGUE (fatigue) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history provided).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (Didn't feel good), HEADACHE (headache) and FATIGUE (fatigue). At the time of the report, MALAISE (Didn't feel good), HEADACHE (headache) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   patient said her send dose schedule on 05 feb,2021. no concomitant and treatment provided
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Palpitations, Rhinorrhoea, Vaccination site pain
Clinical narrative: Palpitations; Running nose; Extreme injection site pain; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Palpitations), RHINORRHOEA (Running nose), VACCINATION SITE PAIN (Extreme injection site pain) and FATIGUE (Fatigue) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PALPITATIONS (Palpitations), RHINORRHOEA (Running nose), VACCINATION SITE PAIN (Extreme injection site pain) and FATIGUE (Fatigue). At the time of the report, PALPITATIONS (Palpitations), RHINORRHOEA (Running nose), VACCINATION SITE PAIN (Extreme injection site pain) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 03-Feb-2021: TCR form - added email
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Myalgia, Nausea, Pyrexia
Clinical narrative: Nauseous; Body Aches; Joint Pain; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nauseous), MYALGIA (Body Aches), ARTHRALGIA (Joint Pain), CHILLS (Chills) and PYREXIA (Fever) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced NAUSEA (Nauseous), MYALGIA (Body Aches), ARTHRALGIA (Joint Pain), CHILLS (Chills) and PYREXIA (Fever). At the time of the report, NAUSEA (Nauseous), MYALGIA (Body Aches), ARTHRALGIA (Joint Pain), CHILLS (Chills) and PYREXIA (Fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information was provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: The patient reported that the events nausea, myalgia, arthralgia, chills and fever got recovered.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Pyrexia, Vaccination site pain
Clinical narrative: Arm hurts at the injection site; Chills; Headache; Body aches; Fever; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), MYALGIA (Body aches) and PYREXIA (Fever) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     The patient's past medical history included Aneurysm. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced HEADACHE (Headache), MYALGIA (Body aches) and PYREXIA (Fever). At the time of the report, HEADACHE (Headache), MYALGIA (Body aches) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Myalgia, Nausea, Vomiting
Clinical narrative: Nausea; Vomiting; weakness; Bodyaches; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea), VOMITING (Vomiting), ASTHENIA (weakness) and MYALGIA (Bodyaches) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L75A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history provided). Concomitant products included PAROXETINE HYDROCHLORIDE (PAXIL [PAROXETINE HYDROCHLORIDE]), LISINOPRIL, PROPRANOLOL HYDROCHLORIDE (INDERAL) and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced NAUSEA (Nausea), VOMITING (Vomiting), ASTHENIA (weakness) and MYALGIA (Bodyaches). At the time of the report, NAUSEA (Nausea), VOMITING (Vomiting), ASTHENIA (weakness) and MYALGIA (Bodyaches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.